BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19915346)

  • 1. [Molecular pathogenesis of leukemias].
    Kurokawa M
    Rinsho Ketsueki; 2009 Oct; 50(10):1382-8. PubMed ID: 19915346
    [No Abstract]   [Full Text] [Related]  

  • 2. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
    Cuenco GM; Ren R
    Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemogenesis by CBF oncoproteins.
    Friedman AD
    Leukemia; 1999 Dec; 13(12):1932-42. PubMed ID: 10602413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
    Cuenco GM; Ren R
    Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin remodeling and leukemia: new therapeutic paradigms.
    Redner RL; Wang J; Liu JM
    Blood; 1999 Jul; 94(2):417-28. PubMed ID: 10397708
    [No Abstract]   [Full Text] [Related]  

  • 7. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
    Daser A; Rabbitts TH
    Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992
    [No Abstract]   [Full Text] [Related]  

  • 8. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
    Tokita K; Maki K; Mitani K
    Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse.
    Maki K; Yamagata T; Yamazaki I; Oda H; Mitani K
    Leukemia; 2006 Aug; 20(8):1458-60. PubMed ID: 16761014
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of EVI1 in normal and leukemic cells.
    Buonamici S; Chakraborty S; Senyuk V; Nucifora G
    Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.
    Takeshita M; Ichikawa M; Nitta E; Goyama S; Asai T; Ogawa S; Chiba S; Kurokawa M
    Leukemia; 2008 Jun; 22(6):1241-9. PubMed ID: 18337762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
    Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms in the development of acute myeloid leukemia].
    Ichikawa M; Kurokawa M
    Nihon Rinsho; 2009 Oct; 67(10):1889-93. PubMed ID: 19860185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.
    Woo HY; Kim DW; Park H; Seong KW; Koo HH; Kim SH
    J Korean Med Sci; 2005 Feb; 20(1):36-41. PubMed ID: 15716599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia.
    Schichman SA; Canaani E; Croce CM
    JAMA; 1995 Feb; 273(7):571-6. PubMed ID: 7837391
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.
    Vinatzer U; Taplick J; Seiser C; Fonatsch C; Wieser R
    Br J Haematol; 2001 Sep; 114(3):566-73. PubMed ID: 11552981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.
    Nucifora G; Begy CR; Kobayashi H; Roulston D; Claxton D; Pedersen-Bjergaard J; Parganas E; Ihle JN; Rowley JD
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4004-8. PubMed ID: 8171026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.